Safety of Gemtuzumab Ozogamicin As Monotherapy or Combination Therapy in an Expanded-Access Protocol for Patients with Relapsed or Refractory Acute Myeloid Leukemia
| Autor: | Wang, Eunice S., Aplenc, Richard, Chirnomas, Deborah *, Dugan, Michael John, Fazal, Salman, Iyer, Swaminathan *, Lin, Tara L, Nand, Sucha, Pierce, Kristen J *, Shami, Paul J, Vermette, Jennifer J *, Abboud, Camille N |
|---|---|
| Zdroj: | In Blood 29 November 2018 132 Supplement 1:3979-3979 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|